Borderline ovarian tumors in Sweden 1960-2005: Trends in incidence and age at diagnosis compared to ovarian cancer

International Journal of Cancer

Volumn 123, Issue 8, 2008, Pages 1897-1901

  Skírnisdóttir, Ingiridur ^a,b   Garmo, Hans ^b   Wilander, Erik ^b   Holmberg, Lars ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Age at diagnosis; Borderline ovarian tumors; Incidence; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; RISK FACTOR; SWEDEN;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PRECANCEROUS CONDITIONS; REGISTRIES; SWEDEN;

EID: 51949100682     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23724     Document Type: Article

References (34)

1. Ozols RF, Rubin SC, Thomas G, Robboy S. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and practice of gynecologic oncology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1997:919-86.
2. Auranen A, Grénman S, Mäkinen J, Pukkala E, Salmi T. Borderline ovarian tumors in Finland: epidemiology and familial occurence. Am J Epidemiol 1996;144:548-53.
3. Björge T, Engeland A, Hansen S, Tropé CG. Trends in incidence of ovarian cancer and borderline tumors in Norway, 1954-1993. Int J Cancer 1997;71:780-6.
4. Skírnisdottir I, Garmo H, Holmberg L. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer. Gynecol Oncol 2007;105:166-71.
5. Kjärbye-Thygesen A, Drasbek Husom L, Fredriksen K, Krüger Kjär S. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries. Acta Obstet Gynecol Scand 2005;84:1006-12.
6. Zhang J, Ugnat AM, Clarke K, Mao Y. Ovarian cancer histology-specific incidence trends in Canada 1969-1993: age-period-cohort analyses. Br J Cancer 1999;81:152-8.
7. Adami HO, Bergstrom R, Persson I, Sparren P. The incidence of ovarian cancer in Sweden 1960-84. Am J Epidemiol 1990;132:446-52.
8. Ewertz M, Kjaer SK. Ovarian cancer incidence and mortality in Denmark, 1942-1982. Int J Cancer 1988;42:690-6.
9. Koper NP, Kiemeney LA, Massuger LF, Thomas CG, Schijf CT, Verbeek AM. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in the Netherlands. Obstet Gynecol 1996;88:387-93.
10. Plaxe SC, Braly PS, Freddo JL. Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancer. Obstet Gynecol 1993;81:651-1.
11. Ayhan A, Guven S, Guven ESG, Kucukali T. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors? Acta Obstet Gynecol 2007;86:484-90.
12. Ödegaard E, Staff AC, Langebrekke A, Engh V, Onsrud M. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy. Acta Obstet Gynecol 2007;86:620-6.
13. Morice P, Camatte S, Wicart-Poque F, Atallah D, Rouzier R, Pautier P, Pomel C, Lhommé C, Duvillard P, Castaigne D. Results of conservative management of epithelial malignant and borderline ovarian tumors. Hum Reprod Update 2003;9:185-92.
14. Kumpulainen S, Kuoppala T, Leminen A, Komulainen M, Puistola U, Sankila R, Mäkinen J, Grénman S. Surgical staging, treatment, and follow-up of borderline tumors in different hospital categories: a prospective nationwide survey in Finland. Acta Obstet Gynecol 2007;86:610-4.
15. Gershenson DM. contemporary treatment of borderline ovarian tumors. Cancer Invest 1999;17:206-10.
16. Fukomoto M, Nakayama K. Ovarian epithelial tumors of low malignant potential. Are they precursors of ovarian carcinoma? Pathol Int 2006;56:233-9.
17. Percy C, van Holten V, Muir C, eds. International classification of diseases for oncology, 2nd edn. Geneva: World Health Organization, 1990.
18. Breslow NE, Day NE. Statistical methods in cancer research. Vol. II. The designed analysis of cohort studies. IARC Sci Publ 1987;2:1-406.
19. Scott DW. Multivariate density estimation. Theory, practice and visualization. New York: Wiley, 1992.
20. Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
21. Cancer Incidence in Sweden 2003. Socialstyrelsen. The national board of heath and welfare, Vol. 10. Stockholm: Statistics health and Diseases, 2004.
22. Levi F, Franceschi S, La Veecchia C, ruzicka J, Gloor E, Randimbison L. Epidemiologic pathologi of ovarian cancer from the Vaud cancer Registry. Switzerland. Ann Oncol 1993;4:289-94.
23. Kaern J, Tropé CG, Kristensen GB, Abeler VM, Pettersen EO. DNA ploidy: the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer 1993;3:349-58.
24. International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumours in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1-7.
25. Morris CR, Rodriguez AO, Epstein J, Cress RD. Declining trends of epithelial ovarian cancer in California. Gynecol Oncol 2008;108:207-13.
26. Risch HA, Marett LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histologic type: results of a case-control study. Am J Epidemiol 1996;144:363-72.
27. Mink PJ, Sherman ME, Devesa SS. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States (Results from the SEER program, 1978-1998). Cancer 2002;95:2380-9.
28. Riman T, Dickman PW, Nilsson S, Correia N, Nordlinder H, Magnusson CM, Persson IR. Risk factors for epithelial borderline ovarian tumors: Results of a Swedish case-control study. Gynecol Oncol 2001;83:575-85.
29. Shih I-M, Kurman RJ. Pathogenesis of ovarian borderline tumors: new insights and old challenges. Clin Cancer Res 2005;11:7273-9.
30. Shih I-M, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analyses. Am J Pathol 2004;164:1511-18.
31. Harris R, Whittemore AS, Itnyre J, and the Collaborative Ovarian cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial ovarian tumors of low malignant potential in white women. Am J Epidemiol 1992;136:1204-11.
32. Kumle M, Weiderpass E, Braaten T, Adami H-O, Lund E. Risk for invasive and borderline epithelial ovarian neoplasias following use of hormonal contraceptives: the Norwegian-Swedish Women's Lifestyle and health Cohort Study. Br J Cancer 2004;90:1386-91.
33. Beral V, Doll R, Hermon C, Peto R, Reeves G, Brinton L, Green AC, Marchbanks P, Negri E, Ness R, Peeters P, Vessey M. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls. Lancet 2008;371:303-14. Available at: www.thelancet.com.
34. Rossing MA, Tang MTC, Flagg EW, Weiss LK, Wicklund KG. A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs. Am J Epidemiol 2004;160:1070-8.